These results further encouraged us to predict that Rg1, Rb1, and Rd could be the most important therapeutic ingredients to MI diseases, and TS IIA was more powerful than the others three TSs, DHTS I, CTS, and TS I in the GDDP. This evidence concerns the gene PPP1R3A and myocardial infarction.